Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

The trial is structured to assess the safety and efficacy of the therapy in approximately 50 ATTRv-PN subjects.

Hair dyes can be an exciting way to refresh your look, but understanding their risks ensures you make informed beauty choices ...

Pharvaris (PHVS) announced that the European Commission has granted orphan designation to its investigational drug, deucrictibant, for the ...

Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases ...

Brandi Glanville said she's getting more support from social media users than from doctors as she navigates facial ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

The following is a summary of “Origin of YouTube videos on hereditary angioedema matters,” published in the March 2025 issue ...

The following is a summary of “Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study,” ...

US-based biopharmaceutical company KalVista Pharmaceuticals has finished enrolling subjects in its KONFIDENT-KID trial of ...

Pharmaceuticals announced the completion of enrollment in the open-label KONFIDENT-KID clinical trial of sebetralstat, an ...